Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
Takeshi Yoshida(Moffitt Cancer Center), Junji Matsui(Eisai (Japan))
Cited by 355
Related Papers
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
|Cancer Medicine|2018|258
Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells
|Journal of Biological Chemistry|2004|217
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
|PLoS ONE|2016|98
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib‐resistant non‐small cell lung cancer cells with acquired <i>MET</i> amplification
|Cancer Science|2009|60
Tubulin is a molecular target of the Wnt-activating chemical probe
|BMC Biochemistry|2016|13